PRISM BioLab Co Ltd (206A)

Currency in JPY
130.00
+3.00(+2.36%)
Closed·
Advertisement
Trading near 52-week Low
206A is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
125.00130.00
52 wk Range
125.00279.00
Key Statistics
Bid/Ask
126.00 / 131.00
Prev. Close
127
Open
126
Day's Range
125-130
52 wk Range
125-279
Volume
103.5K
Average Volume (3m)
332.51K
1-Year Change
-45.3782%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
206A Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
14/05/2026
EPS / Forecast
-8.60 / --
Revenue / Forecast
121M / --
EPS Revisions
Last 90 days

Compare 206A to Peers and Sector

Metrics to compare
206A
Peers
Sector
Relationship
P/E Ratio
−4.9x14.3x−0.4x
PEG Ratio
−0.210.180.00
Price/Book
2.2x1.0x2.6x
Price / LTM Sales
6.6x1.4x3.0x
Upside (Analyst Target)
-31.5%56.2%
Fair Value Upside
Unlock12.4%8.9%Unlock

PRISM BioLab Co.,LTD engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology. It develops E7386 targeting CBP/beta-catenin, which is in Phase II clinical trial for the treatment of cancer; and PRI724 targeting CBP/beta-catenin that is in Phase II clinical trial for treating cirrhosis. The company has a strategic collaboration with Receptor.AI Inc. for the development of an AI-integrated drug discovery platform. The company was founded in 2006 and is based in Fujisawa, treating Japan.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
50.40K0.14%6.80M
Other Institutional Investors
30.97M83.79%4.18B
Public Companies & Retail Investors
5.94M16.08%802.17M
Total
36.96M100.00%4.99B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
DBJ Capital Co., Ltd.15.32%5,662,100764,384
DBJ Capital Fund15.32%5,662,100764,384

FAQ

What Is the PRISM BioLab (Tokyo: 206A) Share Price Today?

The PRISM BioLab stock price today is 130.00 JPY.

What Stock Exchange Does PRISM BioLab (206A) Trade On?

PRISM BioLab is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for PRISM BioLab?

The stock symbol (also called a 'ticker') for PRISM BioLab is "206A."

What Is the Current PRISM BioLab Market Capitalisation?

As of today, PRISM BioLab (Tokyo: 206A) market cap is 4.81B JPY.

What Is PRISM BioLab's (206A) Earnings Per Share (TTM)?

The PRISM BioLab EPS is currently -26.13 (Trailing Twelve Months).

When Is the Next PRISM BioLab Earnings Date?

PRISM BioLab's next earnings report will be released on 13/08/2026.

Is 206A a Buy or Sell From a Technical Analyst Perspective?

Based on today's PRISM BioLab moving averages and other technical indicators, the daily buy/sell signal for 206A stock is Strong Sell.

How Many Times Has PRISM BioLab Stock Split?

PRISM BioLab has split 0 times. (See the 206A stock split history page for full effective split date and price information.)

What is the current trading status of PRISM BioLab (Tokyo: 206A)?

As of 26/06/2026, PRISM BioLab (206A) is trading at a share price of 130.00 JPY, with a previous close of 127.00 JPY. The stock has fluctuated within a day range of 125.00 JPY to 130.00 JPY, while its 52-week range spans from 125.00 JPY to 279.00 JPY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.